Christopher Weber

Chris Weber is a Senior Scientist at ORIC Pharmaceuticals Inc. since November 2020, specializing in small molecule drug discovery in oncology and leading a group focused on new target conception, validation, and high-throughput screening. Previously, Chris held the position of Postdoctoral Research Fellow in the Gerald Crabtree Lab at Stanford University from September 2014 to October 2020, where notable contributions included the development of mESC lines using CRISPR/Cas9 for studying chromatin remodeling complexes. Chris's academic journey includes a Ph.D. in Molecular and Cellular Biology from the University of Washington and significant research experience at institutions such as Fred Hutchinson Cancer Research Center and the University of California, San Francisco, where foundational research was conducted in chromatin genomics and the genetic basis of hearing impairment, respectively.